Ortin Laboratories Limited (ORTINLAB.NS) NSE

Currency In INR

AD

Valuation

Market Cap149.6M
Enterprise Value144.2M
P/E Ratio-14.25
PEG Ratio2.02
Price/Sales Ratio168.46
Price/Book Ratio10.44
Enterprise/Revenue173.66
Enterprise/EBITDA-14.93

Fiscal Year

Fiscal YearMarch 31, 2024
Most Recent QuarterMarch 31, 2024

Profitability

Profit Margin-11.77
Operating Margin-15.21
AD

Management Effectiveness

Return On Assets-0.19
Return On Equity-0.62

Income Statement

Revenue21.12M
Revenue/Share0.09
Gross Profit-23.94M
EBITDA-63.65M
Net Income-80.41M
Diluted EPS-9.89

Balance Sheet

Total Cash23.43M
Total Cash/Share0.75
Total Debt18.02M
Total Debt/Equity0.81
Current Ratio1.6
Book Value Per Share1.52

Price History

52-Week Change3.99
52-Week High26.35
52-Week Low16.2
Moving Average 50 Days20.24
Moving Average 200 Days20.07

Statistics

Average Volume118,301
Shares Outstanding8.13M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor12:25
Last Split DateJanuary 12, 2021
AD